ctrl K

Watchlist Price Alert

Aligos Therapeutics Inc. (ALGS)

NASDAQ: ALGS · Real-Time Price · USD

4.49

-0.38 (-7.80%)

At close: May 09, 2025, 3:59 PM

4.48

-0.22%

After-hours: May 09, 2025, 04:26 PM EDT

Aligos Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	3.94M	15.53M	13.91M	4.36M	n/a	n/a	n/a
Cost of Revenue	2.62M	3.07M	3.67M	104.15M	3.33M	2.3M	1.29M
Gross Profit	1.32M	12.46M	10.23M	-99.79M	-3.33M	-2.3M	-1.29M
Operating Income	-89.15M	-88.13M	-97.58M	-128.32M	-97.83M	-54.04M	-13.66M
Interest Income	n/a	1.24M	1.64M	132K	1.26M	1.56M	163K
Pretax Income	-130.88M	-86.88M	-95.94M	-128.19M	-108.38M	-52.18M	-13.93M
Net Income	-131.21M	-87.68M	-96.05M	-128.33M	-108.54M	-52.26M	-13.93M
Selling & General & Admin	22.83M	30.62M	26.41M	28.53M	17.94M	10.01M	3.21M
Research & Development	70.27M	73.04M	85.08M	104.15M	79.89M	44.04M	10.46M
Other Expenses	n/a	n/a	n/a	n/a	-10.55M	302K	-435K
Operating Expenses	93.1M	103.66M	111.49M	132.68M	97.83M	54.04M	13.66M
Interest Expense	n/a	n/a	1.64M	132K	10.55M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	93.1M	102.96M	111.49M	132.68M	97.83M	54.04M	13.66M
Income Tax Expense	331K	795K	106K	143K	161K	85K	-272K
Shares Outstanding (Basic)	6.26M	24.87M	42.7M	39.86M	34.18M	21.93M	21.17M
Shares Outstanding (Diluted)	6.26M	24.87M	42.7M	39.86M	34.18M	21.93M	21.17M
EPS (Basic)	-20.94	-3.52	-2.25	-3.22	-3.18	-2.38	-0.66
EPS (Diluted)	-20.94	-3.52	-2.25	-3.22	-3.18	-2.38	-0.66
EBITDA	-89.15M	-85.06M	-93.91M	-124.54M	-105.06M	-49.88M	-12.37M
EBIT	-89.15M	-88.13M	-97.58M	-128.32M	-108.38M	-52.18M	-13.66M
Depreciation & Amortization	n/a	3.07M	3.67M	3.78M	3.33M	2.3M	1.29M